Loading
What changed between revision 1 and revision 2, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/cynthia-kenyon.md — the filesystem corpus, unchanged. Not an edit.
16.2 kB
Revision 1
Revision 2
lines 7–13 → 7–136 unchanged lines not shown
categories: ["people", "longevity"]categories: ["people", "longevity"]tags: ["aging", "genetics", "c. elegans", "insulin signaling", "foxo", "biogerontology"]tags: ["aging", "genetics", "c. elegans", "insulin signaling", "foxo", "biogerontology"]summary: "American molecular geneticist whose 1993 finding that a single daf-2 mutation doubles the lifespan of C. elegans made aging a tractable genetic problem."summary: "American molecular geneticist whose 1993 finding that a single daf-2 mutation doubles the lifespan of C. elegans made aging a tractable genetic problem."updated: "2026-07-27"updated: "2026-10-29"issues: ["Kenyon's UCSF appointments and the year of her election to the National Academy of Sciences are unsourced.", "Her account of changing her own diet is drawn from interviews rather than a citable document."]issues: ["Kenyon's UCSF appointments and the year of her election to the National Academy of Sciences are unsourced.", "Her account of changing her own diet is drawn from interviews rather than a citable document."]------ lines 29–74 → 29–7315 unchanged lines not shown
**Cynthia Kenyon** is an American molecular geneticist whose laboratory showed in 1993 that a**Cynthia Kenyon** is an American molecular geneticist whose laboratory showed in 1993 that amutation in a single gene, *daf-2*, roughly doubles the lifespan of the nematode *Caenorhabditismutation in a single gene, *daf-2*, roughly doubles the lifespan of the nematode *Caenorhabditiselegans*, and that the extension depends entirely on a second gene, *daf-16*. The long-livedelegans*, and that the extension depends entirely on a second gene, *daf-16*. The long-lived animalsanimals stayed active rather than merely surviving longer, a detail that shaped how the result wasstayed active instead of merely surviving longer, a detail that shaped how the result was received.received. Before that experiment, aging was widely treated as dispersed damage with no controlBefore that experiment, aging was widely treated as dispersed damage with no control point and nopoint and no serious genetics; afterwards it was a pathway. Since 2014 she has been vice presidentserious genetics; afterwards it was a pathway. Since 2014 she has been vice president of agingof aging research at [[calico]].research at [[calico]]. ```figure```figure{"key": "c-elegans-adult", "caption": "About a millimetre long and transparent, with a fixed somatic cell count in the adult hermaphrodite \u2014 which is why a lifespan screen was tractable at all."}{"key": "c-elegans-adult", "caption": "About a millimetre long and transparent, with a fixed somatic cell count in the adult hermaphrodite, which is why a lifespan screen was tractable at all."}`````` ## Career## Career Kenyon studied biochemistry at the University of Georgia and took a doctorate at the MassachusettsKenyon studied biochemistry at the University of Georgia and took a doctorate at the MassachusettsInstitute of Technology with Graham Walker, where she showed that DNA-damaging agents switch on aInstitute of Technology with Graham Walker. There she showed that DNA-damaging agents switch on aspecific set of genes in *Escherichia coli*, several of them involved in DNA repair — earlyspecific set of genes in *Escherichia coli*, several of them involved in DNA repair, which was earlyevidence that a cell answers damage with a coordinated transcriptional response. She then joinedevidence that a cell answers damage with a coordinated transcriptional response. She then joinedSydney Brenner's group at the MRC Laboratory of Molecular Biology in Cambridge, where *C. elegans*Sydney Brenner's group at the MRC Laboratory of Molecular Biology in Cambridge, where *C. elegans*had been built into a model organism and its cell lineage was being traced cell by cell.had been built into a model organism and its cell lineage was being traced cell by cell. She joined the University of California, San Francisco in the mid-1980s and worked first on how HoxShe joined the University of California, San Francisco in the mid-1980s and worked first on how Hoxgenes pattern the worm's body. The turn to aging was, by her own account, a deliberate move into agenes pattern the worm's body. By her own account, the turn to aging was a deliberate move into aquestion the field considered unproductive. At UCSF she was a professor in the department ofquestion the field considered unproductive. At UCSF she was a professor in the department ofbiochemistry and biophysics and directed the Hillblom Center for the Biology of Aging. She is abiochemistry and biophysics and directed the Hillblom Center for the Biology of Aging. She is amember of the National Academy of Sciences.member of the National Academy of Sciences. ## Why the result was unexpected## Why the result was unexpected Evolutionary theory gave no reason to expect genes dedicated to aging: selection weakens onceEvolutionary theory gave no reason to expect genes dedicated to aging. Selection weakens oncereproduction ends, so a programme that destroys an old animal has nothing to maintain it. Thereproduction ends, so nothing would maintain a programme that destroys an old animal. The workingworking picture was of damage accumulating across many systems at once — oxidation, proteinpicture was of damage accumulating across many systems at once (oxidation, protein cross-linking,cross-linking, somatic mutation — with no lever anywhere. [[caloric-restriction]] was the onesomatic mutation) with no lever anywhere. [[caloric-restriction]] was the one intervention reliablyintervention reliably known to extend rodent lifespan, and even that had no mechanism attached. Aknown to extend rodent lifespan, and even that had no mechanism attached. A molecular biologist whomolecular biologist who announced plans to find aging genes was assumed to be looking for somethingannounced plans to find aging genes was assumed to be looking for something that did not exist.that did not exist. There had been signals. Michael Klass isolated long-lived worm strains in the early 1980s, andThere had been signals. Michael Klass isolated long-lived worm strains in the early 1980s, andThomas Johnson and David Friedman later characterized one of them, *age-1*, reporting aThomas Johnson and David Friedman later characterized one of them, *age-1*, reporting asubstantially longer mean lifespan together with reduced fertility.[^friedman1988] The work wassubstantially longer mean lifespan together with reduced fertility.[^friedman1988] The work wasknown and did not change the field's mind: a single mutant of unknown mechanism is easy to dismissknown and did not change the field's mind, because a single mutant of unknown mechanism is easy toas sickly or slow.dismiss as sickly or slow. ## The 1993 experiment## The 1993 experiment lines 79–92 → 78–914 unchanged lines not shown
like younger worms well past the age at which the controls had died. Mutating *daf-16* abolished thelike younger worms well past the age at which the controls had died. Mutating *daf-16* abolished theeffect completely: without it, *daf-2* mutants lived an ordinary span.effect completely: without it, *daf-2* mutants lived an ordinary span. That genetic dependency mattered more than the doubling. It showed the extension was not aThe genetic dependency mattered more than the doubling. It showed that the extension came from aby-product of being ill or torpid but the output of a regulatory relationship — *daf-2* signallingregulatory relationship, and was no by-product of being ill or torpid. Normal *daf-2* signallingnormally holds *daf-16* off, and lifting that suppression switches on something that keeps an animalholds *daf-16* off, and lifting that suppression switches on something that keeps the animal alivealive longer. Aging, in at least one animal, had a control point.longer. In at least one animal, aging had a control point. > [!key] What changed in 1993> [!key] What changed in 1993> One mutation, in an otherwise normal animal, in a named pathway, with a clean epistatic> The result combined one mutation, an otherwise normal animal, a named pathway and a clean> dependency on a second gene. That combination made the result impossible to file under "sick> epistatic dependency on a second gene. Together these made it impossible to file under "sick> worms live longer", and laboratories with no interest in gerontology began running lifespan> worms live longer", and laboratories with no interest in gerontology began running lifespan> assays.> assays. lines 95–124 → 94–1242 unchanged lines not shown
In 1997 Gary Ruvkun's laboratory cloned *daf-2* and found that it encodes a receptor of theIn 1997 Gary Ruvkun's laboratory cloned *daf-2* and found that it encodes a receptor of theinsulin/IGF-1 family.[^kimura1997] The same year Kenyon's group and Ruvkun's independentlyinsulin/IGF-1 family.[^kimura1997] The same year Kenyon's group and Ruvkun's independentlyidentified *daf-16* as a forkhead transcription factor, the worm counterpart of the mammalian FOXOidentified *daf-16* as a forkhead transcription factor, the worm counterpart of the mammalian FOXOproteins.[^lin1997] What the 1993 experiment had caught was a nutrient-sensing system conservedproteins.[^lin1997] The 1993 experiment had caught a nutrient-sensing system conserved acrossacross animals rather than a worm peculiarity, which is why the finding travelled.animals, not a worm peculiarity, which is why the finding travelled. Her laboratory then established that worm lifespan is regulated between tissues rather than cell byHer laboratory then established that worm lifespan is regulated between tissues, not cell by cell.cell. Removing germline precursor cells extends lifespan, and signals from the reproductive systemRemoving germline precursor cells extends lifespan, and signals from the reproductive system act onact on DAF-16 elsewhere in the body.[^hsin1999] Combining germline removal with a *daf-2* mutationDAF-16 elsewhere in the body.[^hsin1999] Combining germline removal with a *daf-2* mutation producedproduced animals living roughly six times the normal span and still moving.[^arantes2003] Sensoryanimals that lived roughly six times the normal span and were still moving.[^arantes2003] Sensoryneurons contribute too: worms whose sensory perception is impaired outlive worms that sense theirneurons contribute too: worms whose sensory perception is impaired outlive worms that sense theirsurroundings normally. Downstream, DAF-16 turned out to control hundreds of genes — chaperones andsurroundings normally. Downstream, DAF-16 turned out to control hundreds of genes, among themother [[proteostasis]] machinery, stress-response and antimicrobial genes, metabolic enzymes — sochaperones and other [[proteostasis]] machinery, stress-response and antimicrobial genes, andthe longevity output is itself polygenic, and [[autophagy]] genes are required for it.metabolic enzymes. The longevity output is therefore itself polygenic, and [[autophagy]] genes arerequired for it. One experiment matters particularly for translation. Reducing *daf-2* activity only in adulthood,One experiment matters particularly for translation. Reducing *daf-2* activity only in adulthood,after development is complete, is enough to extend lifespan.[^dillin2002] Worm aging is not lockedafter development is complete, is enough to extend lifespan.[^dillin2002] Worm aging is not lockedin by developmental history, which is the premise every adult-onset intervention rests on.in by developmental history, and every adult-onset intervention rests on that premise. ```timeline```timeline[[ { "year": "1983–1988", "title": "First long-lived worm mutants", "text": "Michael Klass isolates strains that outlive wild type; Friedman and Johnson later characterize age-1. The field takes little notice." }, { "year": "1983-1988", "title": "First long-lived worm mutants", "text": "Michael Klass isolates strains that outlive wild type; Friedman and Johnson later characterize age-1. The field takes little notice." }, { "year": "1993", "title": "daf-2 doubles lifespan", "text": "Kenyon, Chang, Gensch, Rudner and Tabtiang report that a daf-2 mutation roughly doubles C. elegans lifespan and that the effect requires daf-16." }, { "year": "1993", "title": "daf-2 doubles lifespan", "text": "Kenyon, Chang, Gensch, Rudner and Tabtiang report that a daf-2 mutation roughly doubles C. elegans lifespan and that the effect requires daf-16." }, { "year": "1997", "title": "The genes are cloned", "text": "daf-2 proves to encode an insulin/IGF-1-like receptor and daf-16 a forkhead (FOXO) transcription factor, placing worm longevity in a conserved pathway." }, { "year": "1997", "title": "The genes are cloned", "text": "daf-2 proves to encode an insulin/IGF-1-like receptor and daf-16 a forkhead (FOXO) transcription factor, placing worm longevity in a conserved pathway." }, { "year": "1999", "title": "Lifespan is signalled between tissues", "text": "Removing germline precursor cells extends lifespan, showing that the reproductive system regulates aging in the rest of the animal." }, { "year": "1999", "title": "Lifespan is signalled between tissues", "text": "Removing germline precursor cells extends lifespan, showing that the reproductive system regulates aging in the rest of the animal." }, { "year": "2002", "title": "Adult-onset reduction suffices", "text": "Lowering daf-2 activity only after development still extends lifespan, separating aging from developmental programming." }, { "year": "2002", "title": "Adult-onset reduction suffices", "text": "Lowering daf-2 activity only after development still extends lifespan, separating aging from developmental programming." }, { "year": "2003", "title": "IGF-1 receptor mice live longer", "text": "Mice heterozygous for the IGF-1 receptor show a modest lifespan increase, concentrated in females — the mammalian echo of the worm result." }, { "year": "2003", "title": "IGF-1 receptor mice live longer", "text": "Mice heterozygous for the IGF-1 receptor show a modest lifespan increase, concentrated in females: the mammalian echo of the worm result." }, { "year": "2008", "title": "FOXO3 and human survival", "text": "Variants near FOXO3 are associated with exceptional longevity in a Japanese-American cohort, and the association replicates in other populations." }, { "year": "2008", "title": "FOXO3 and human survival", "text": "Variants near FOXO3 are associated with exceptional longevity in a Japanese-American cohort, and the association replicates in other populations." }, { "year": "2014", "title": "Kenyon joins Calico", "text": "She moves from UCSF to the aging-research company Google founded the year before, as vice president of aging research." } { "year": "2014", "title": "Kenyon joins Calico", "text": "She moves from UCSF to the aging-research company Google founded the year before, as vice president of aging research." }]]lines 126–143 → 126–1431 unchanged line not shown
## From worms to mammals## From worms to mammals Reduced insulin/IGF-1 signalling extends lifespan in fruit flies and, more modestly, in mice: animalsReduced insulin/IGF-1 signalling extends lifespan in fruit flies and, more modestly, in mice.heterozygous for the IGF-1 receptor live longer, with the effect concentrated inAnimals heterozygous for the IGF-1 receptor live longer, with the effect concentrated infemales,[^holzenberger2003] and dwarf mice with defective growth hormone signalling are among thefemales,[^holzenberger2003] and dwarf mice with defective growth hormone signalling are among thelongest-lived laboratory strains. The direction is consistent across species and the magnitudelongest-lived laboratory strains. The direction is consistent across species, and the magnitudeshrinks as the animal gets more complicated. A worm doubles. A mouse gains a fraction of that, oftenshrinks as the animal gets more complicated. Where a worm doubles its lifespan, a mouse gains ain one sex only, and the long-lived growth hormone mutants carry small body size and altered glucosefraction of that, often in one sex only, and the long-lived growth hormone mutants carry small bodyhandling with them.size and altered glucose handling with them. In humans the pathway appears in genetics rather than in trials. Variants near FOXO3 are among theIn humans the pathway appears in genetics, not in trials. Variants near FOXO3 are among the fewfew associations with exceptional survival that have replicated across populations.[^willcox2008]associations with exceptional survival that have replicated across populations.[^willcox2008] PeoplePeople with inherited growth hormone receptor deficiency, who have very low circulating IGF-1, havewith inherited growth hormone receptor deficiency, who have very low circulating IGF-1, have beenbeen reported to be nearly free of diabetes and cancer without living longer than theirreported to be nearly free of diabetes and cancer without living longer than theirrelatives.[^guevara2011] Studies of centenarian families, including the cohorts assembled byrelatives.[^guevara2011] Studies of centenarian families, including the cohorts assembled by[[nir-barzilai]], keep implicating growth and insulin signalling without yielding an intervention.[[nir-barzilai]], keep implicating growth and insulin signalling without yielding an intervention. lines 146–189 → 146–1912 unchanged lines not shown
The immediate objection in 1993 was that the mutants might simply have diverted into a dauer-likeThe immediate objection in 1993 was that the mutants might simply have diverted into a dauer-liketorpor and be living longer by living less. Kenyon's emphasis on their activity, the cloning of thetorpor and be living longer by living less. Kenyon's emphasis on their activity, the cloning of thegenes, and the later demonstration that adult-onset reduction works answered most of that. Within agenes, and the later demonstration that adult-onset reduction works answered most of that. Within adecade the subject had funding, dedicated journals and dedicated institutes; the organizing claimdecade the subject had funding, dedicated journals and dedicated institutes. Its organizing claim,that treating aging itself would postpone several diseases at once was later formalized as thethat treating aging itself would postpone several diseases at once, was later formalized as the[[geroscience-hypothesis]].[[geroscience-hypothesis]]. Two criticisms have not gone away. The first is that the worm's adult soma is post-mitotic with aTwo criticisms have not gone away. The first is that the worm's adult soma is post-mitotic with afixed cell number, so much of what kills mammals has no counterpart in it: no somaticfixed cell number, so much of what kills mammals has no counterpart in it. The worm has no somatic[[stem-cell-exhaustion]], no dividing cells to accumulate [[telomeres-and-telomerase|telomere[[stem-cell-exhaustion]], no dividing cells to accumulateattrition]], no analogue of the mammalian [[cellular-senescence]] that [[senolytics]] are built to[[telomeres-and-telomerase|telomere attrition]], and no analogue of the mammalianclear. Several of the [[hallmarks-of-aging]] are not testable in a nematode, and a pathway that sets[[cellular-senescence]] that [[senolytics]] are built to clear. Several of thethe rate of decline there need not bound [[maximum-human-lifespan]]. The second is that *daf-2*[[hallmarks-of-aging]] cannot be tested in a nematode, and a pathway that sets the rate of declinemutants pay for their longevity in ways the headline number hides: reduced brood size, and athere need not bound [[maximum-human-lifespan]]. The second is that *daf-2* mutants pay for theirphysiology partly resembling the stress-resistant dauer state the genes were named for.longevity in ways the headline number hides: reduced brood size, and a physiology partly resemblingthe stress-resistant dauer state the genes were named for. > [!debate] A programme for aging, or a repurposed survival programme> [!debate] A programme for aging, or a repurposed survival programme> Kenyon has argued that animals carry a regulatory system that sets the rate of aging and that it> Kenyon has argued that animals carry a regulatory system that sets the rate of aging and that it> can be turned down. Critics read the same experiments as a nutrient-sensing switch into a> can be turned down. Critics read the same experiments as a nutrient-sensing switch into a> stress-resistant, low-growth state that happens to postpone death — conserved and real, but not> stress-resistant, low-growth state that happens to postpone death. On that reading the switch is> the same claim. The distinction decides whether "the aging pathway" is a drug target or a> conserved and real, but the claim is a different one. The distinction decides whether "the aging pathway" is a drug> metaphor.> target or a metaphor. ## Legacy## Legacy The 1993 paper is much of the reason biogerontology can be funded as molecular biology. It made *C. elegans*The 1993 paper is much of the reason biogerontology can be funded as molecular biology. It made *C.the workhorse of the field, supporting compound screens, standardized lifespan assays andelegans* the workhorse of the field, supporting compound screens, standardized lifespan assays andmulti-laboratory replication efforts. Arguments that aging is a treatable condition rather than amulti-laboratory replication efforts. Arguments that aging is a treatable condition and not a fixedfixed fact of biology, pressed by [[aubrey-de-grey]] and later by [[david-sinclair]], rest on anfact of biology, pressed by [[aubrey-de-grey]] and later by [[david-sinclair]], rest on anexperimental anchor that did not exist before 1993, and the institutional build-out that followedexperimental anchor that did not exist before 1993. The institutional build-out that followed runsruns from the [[buck-institute]] through Calico to [[altos-labs]]. The [[longevity-dividend]] case for treating aging as a public health target restsfrom the [[buck-institute]] through Calico to [[altos-labs]]. The [[longevity-dividend]] case foron the premise her worms supplied: that the rate of aging is adjustable at all. Kenyon has framedtreating aging as a public health target rests on the premise her worms supplied: that the rate ofthe goal as [[healthspan]] rather than years alone, on the grounds that her mutants did not merelyaging can be adjusted at all. Kenyon has framed the goal as [[healthspan]] rather than years alone,persist, they stayed young longer.on the grounds that her mutants did not merely persist; they stayed young longer. What the pathway has not produced is a human intervention. Nothing acting on insulin/IGF-1 signallingThe pathway has not produced a human intervention. Nothing acting on insulin/IGF-1 signalling hashas been shown to slow human aging; [[rapamycin]] and [[metformin]] work on adjacent nutrient-sensingbeen shown to slow human aging. [[rapamycin]] and [[metformin]] work on adjacent nutrient-sensingbiology and remain unproven for that purpose in people; no [[aging-biomarkers|surrogate endpoint]]biology and remain unproven for that purpose in people. No [[aging-biomarkers|surrogate endpoint]]has been qualified by a regulator, so no trial design would settle the question quickly; and thehas been qualified by a regulator, so no trial design would settle the question quickly, and thegenetic route, whether by [[gene-therapy-for-aging]] or otherwise, has no human-validated target.genetic route, whether by [[gene-therapy-for-aging]] or otherwise, has no human-validated target.The worm result changed what questions the field may ask, not what can be prescribed.The worm result changed which questions the field may ask; it has not changed what can beprescribed. > [!caution] What the worm result does not license> [!caution] What the worm result does not license> Kenyon has described cutting sugar and starch from her own diet after work in her laboratory> Kenyon has described cutting sugar and starch from her own diet after work in her laboratorylines 192–202 → 194–2042 unchanged lines not shown
> best-supported way to compress late-life decline in humans is still> best-supported way to compress late-life decline in humans is still> [[exercise-and-aging|exercise]].> [[exercise-and-aging|exercise]]. The open question is the one the 1993 result created. Nematode lifespan can be dialled by a singleThe open question is the one the 1993 result created. A single receptor can dial nematode lifespanreceptor; mammalian lifespan responds to the same receptor by tens of percent, with costs in growth,up; mammalian lifespan responds to the same receptor by tens of percent, with costs in growth,fertility and metabolism attached. Whether that ratio reflects a translation problem that betterfertility and metabolism attached. It is unresolved whether that ratio reflects a translationmolecules will solve, or a real difference between an animal with a fixed soma and one with dividingproblem that better molecules will solve, or a real difference between an animal with a fixed somatissue and cancer, is unresolved — and it decides whether the pathway is a route to humanand one with dividing tissue and cancer. The answer decides whether the pathway is a route to human[[negligible-senescence|slowed aging]] or a beautiful piece of worm biology.[[negligible-senescence|slowed aging]] or a beautiful piece of worm biology. ## See also## See alsoremoved, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
147 lines are the same in both revisions, and 55 of them are not shown. Neither revision here is necessarily the current article — read Cynthia Kenyon for the text this wiki stands behind today.